AccuLine announced pilot study results demonstrating 94% sensitivity and 99% NPV for CORA in the detection of significant CAD
Read the article
14/07/2024
Israeli startup raises $4.2 million Seed round to detect heart attacks early
Read the article
28/09/2023
AccuLine Announces Know-How License Agreement with Mayo Clinic to Advance Early Detection of Heart Attacks
Read the article
22/11/2022
AccuLine was chosen to the RISE With US program
Read the article
27/10/2022
AccuLine is one of the finalists in the Reboot Forum “Leading Health Initiative of the Year” competition
Read the article
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.